Breast Cancer Clinical Trials

Showing 21-40 of 5,597 trials

A Clinical Trial Comparing the Efficacy and Safety of Different Doses of BL0175 Injection in Treating Postmenopausal Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Locally Advanced or Metastatic Breast Cancer

NCT07658183

The goal of this clinical trial is to compare the objective response rates (ORR) of different doses of BL0175 in patients with postmenopausal hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative locally advanced or metastatic breast cancer. The main questions it aims to answer are: 1. Which dose level of BL0175 demonstrates the optimal ORR? 2. What is the recommended phase 3 dose (RP3D) based on efficacy and safety data across the tested dose levels?

Breast Cancer (Locally Advanced or Metastatic)

Shanghai Best-Link Bioscience, LLC120 participantsStarted Jul 2026

RECRUITING

Emotional Distress in Patients With Metastatic Breast Cancer in First Line of Therapy

NCT06994377

Few data about the impact of emotional distress (ED) on treatment efficacy in patients with metastatic breast cancer (mBC) are available. Aim of this study is to assess the outcomes of patients with mBC receiving first-line treatment according to the presence of baseline ED.

Metastatic Breast Cancer

European Institute of Oncology1,000 participantsStarted Jun 2025

Ancona, Italy • Aviano, Italy • Bagno a Ripoli, Italy +34 more locations

A Clinical Trial Comparing the Efficacy and Safety of Different Doses of BL0175 Injection in Treating Postmenopausal Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Locally Advanced or Metastatic Breast Cancer

Emotional Distress in Patients With Metastatic Breast Cancer in First Line of Therapy

Related Searches

Cachexia and Gut Microbiota in Patients With Breast Cancer Receiving Home Care

A Vaccine (MV-s-NAP) for the Treatment of Patients With Invasive Metastatic Breast Cancer

Probiotics for Prevention of Neratinib-Induced Diarrhea in Breast Cancer Patients

A Study of Camizestrant in ER+/HER2- Early Breast Cancer After at Least 2 Years of Standard Adjuvant Endocrine Therapy

Finding the Best Tamoxifen Dose for Breast Cancer Risk Reduction in Premenopausal Women, RENAISSANCE Trial

Veliparib, Paclitaxel, and Carboplatin in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery and Liver or Kidney Dysfunction

PALbociclib CoLlaborative Adjuvant Study

A Clinical Study on Prophylactic RespOnse To hEtrombopag for Secondary Prevention in Anti-Cancer Therapy-induced Thrombocytopeniae

Trastuzumab Deruxtecan Plus ivonescImab for Hormone Receptor-positive HER2 Negative Advanced Breast Cancer Study

18F FES-PET/MRI for Tailoring Treatment of Luminal A and Lobular Breast Cancer

PhII Randomized CAPecitabine + ELAcestrant vs. Capecitabine Alone in ER+ Breast Cancer (CAPELA)

MammoVerse: Clinicians Focus Group

HER2 FPBMC in Patients With Metastatic Breast and Prostate Cancer (AM006)

Efti in Patients With Hormone Receptor Positive/HER2-neg Breast Cancer

Effect of Yoga Program on Quality of Life in Women With Breast Cancer Receiving Endocrine Therapy

MEM-288 Oncolytic Virus Alone and in Combination With Standard of Care Therapy in Advanced Solid Tumors

Avapritinib for the Treatment of CKIT or PDGFRA Mutation-Positive Locally Advanced or Metastatic Malignant Solid Tumors

Magnetic Resonance Imaging in Radiotherapy for Breast Cancer